1762 — Chunghwa Chemical Synthesis & Biotech Co Income Statement
0.000.00%
Last trade - 00:00- TWD2.76bn
- TWD3.35bn
- TWD804.88m
Annual income statement for Chunghwa Chemical Synthesis & Biotech Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,935 | 2,117 | 2,086 | 1,347 | 805 |
| Cost of Revenue | |||||
| Gross Profit | 949 | 962 | 757 | 394 | -8.86 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,496 | 1,654 | 1,806 | 1,341 | 1,124 |
| Operating Profit | 438 | 464 | 281 | 6.34 | -319 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 498 | 583 | 333 | 57.2 | -256 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 401 | 466 | 265 | 53 | -244 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 401 | 466 | 265 | 53 | -244 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 401 | 466 | 265 | 53 | -244 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.12 | 5.94 | 3.39 | 0.932 | -4.39 |
| Dividends per Share |